Company / Shareholders' Equity
NP Life Sciences Health Industry Group Inc. Shareholders' Equity History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$16.4K
FY2023
5-year range
$16.4K / $234.9K
FY2019-FY2023
Trend
-15.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has declined for 4 consecutive years, from $234,914 in FY2019 to $16,381 in FY2023.
Based on SEC 10-K filings.
$16,381 in FY2023 with a 3-year CAGR of -46.0%.
Declined from $38,172 to $16,381 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -46.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NP Life Sciences Health Industry Group Inc.'s shareholders' equity has declined for 4 consecutive years.
- 3-year CAGR of -46.0%, indicating a declining trend.
- In FY2023, shareholders' equity decreased 15.2% year-over-year.
- Peak shareholders' equity was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $16.4K | -15.2% |
| FY2022 | $19.3K | -49.4% |
| FY2021 | $38.2K | -63.2% |
| FY2020 | $103.8K | -55.8% |
| FY2019 | $234.9K | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026